Endava's stock is underperforming, with the company missing quarterly earnings and revenue estimates and reporting a net loss and goodwill impairment. Some analysts believe the stock has potential for a bounce back, while others have downgraded it due to weak demand and execution risks. The company's margins and potential disruption from ai are also being cited as concerns, leading to uncertainty about its ability to recover.